Blood Flow Restriction Resistance Exercise and Cardiac Cycle Dynamics

ConditionCardiac
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorMontclair State University

About this trial

Blood flow restriction resistance exercise uses partial vascular occlusion of a limb during low weight resistance exercises to stimulate muscle strengthening and growth. This is commonly used during rehabilitation from an injury. Because blood flow in and out of the limbs is decreased, this may have consequences for blood flow through the heart. The purpose of this study will be to test cardiac dynamics during blood flow restriction resistance exercise to determine if cardiac blood flow is impacted. It is hypothesized that both non-BFR exercise and BFR exercise will increase heart rate shortening various cardiac cycle parameters, but BFR exercise will increase the isovolumetric contraction time vs non-BFR exercise due to an increase in total peripheral resistance. It is also hypothesized that BFR exercise will lower early ventricular filling parameters due to lower venous return.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Generally healthy

Disqualifiers

Uncontrolled hypertension

Peripheral vascular disease

Lymphedema

Sickle cell anemia

Trial design

Design model

Single group

Treatments tested in this trial

  • Blood flow restriction resistance exercise

    Behavioral

    Blood flow in and out of the limb will be artificially with an occlusion cuff.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Intervention groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Cardiac cycle durations

Time frame
During the intervention for approximately 10 minutes.
2

Ventricular filling

Time frame
During intervention phase for approximately 10 minutes.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: